External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

Angiogenesis 2024

-
Coming soon
05:40 PM
Duration 10mins Virtual
Microperimetry Endpoints: An Updated Analysis of the Lampalizumab Clinical Trial Data
Ip M

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:50 PM
Duration 10mins Virtual
Targeting Ang2 and VEGF - Biology, Pharmacokinetics and Latest Clinical Data in nAMD and DME
Lim J

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:00 PM
Duration 10mins Virtual
Emerging Imaging and Biological Markers Supporting Angiopoietin-2 in nAMD and DME
Singh R

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:10 PM
Duration 10mins Virtual
Faricimab▼ in RVO: 72-Week Results From the BALATON and COMINO Phase 3 Studies
Tadayoni R

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:20 PM
Duration 10mins Virtual
Voyager Study- Update on Faricimab▼ in the Real World
Guymer R

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:10 AM
Duration 10mins Virtual
The Path Forward for PDS: Technical Data Supporting Device Improvements and Septum Dislodgement Mitigation
Pieramici D

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:20 AM
Duration 10mins Virtual
The Impact of Continuous Delivery of Ranibizumab With PDS on Retinal Nonperfusion in Diabetic Retinal Disease
Campochiaro P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar